Women's Angiographic Vitamin and Estrogen Trial (WAVE)
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
To assess whether hormonal replacement therapy and/or antioxidant treatment would stabilize
or inhibit progression, and induce regression of coronary plaques. The mechanisms by which
these treatments modified atherosclerosis in women were also explored.